GLP-1 receptor agonists expand treatment options for diabetes, weight loss, and more, showing promise in heart failure, kidney disease, and neuroprotection.
Luke Evans, PharmD Candidate 2026
Advertisement
Articles by Luke Evans, PharmD Candidate 2026
Advertisement
Latest Updated Articles
Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding IndicationsPublished: November 26th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
BTK Inhibitors with CAR T-cell Therapy
2
National Pharmacist Day Spotlight: The Expanding Role of Pharmacists in Serious Mental Illness Care
3
Concomitant Use of Tirzepatide, Ixekizumab Improves PsA Disease Activity and Promotes Weight Reduction
4
Updated Guidelines Reflect Advances in CKD Management
5